Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-12-30 6:51 pm Purchase | 2024-12-26 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 39,709,850 31.900% | 16,929,507 (+74.32%) | Filing History |
2024-12-06 5:30 pm Purchase | 2024-11-29 | 13G | Alector, Inc. ALEC | RA Capital Management, L.P. | 9,695,228 9.900% | 9,695,228 (New Position) | Filing History |
2024-12-05 6:55 pm Purchase | 2024-11-27 | 13G | Kura Oncology, Inc. KURA | RA Capital Management, L.P. | 4,368,998 5.600% | 4,368,998 (New Position) | Filing History |
2024-11-26 5:32 pm Purchase | 2024-11-26 | 13D | Cidara Therapeutics, Inc. CDTX | RA Capital Management, L.P. | 1,092,796 9.990% | 389,716 (+55.43%) | Filing History |
2024-11-22 4:12 pm Purchase | 2024-11-15 | 13G | Arcellx, Inc. ACLX | RA Capital Management, L.P. | 2,787,327 5.200% | 2,787,327 (New Position) | Filing History |
2024-11-18 8:19 pm Unchanged | 2024-11-14 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 14,254,298 11.900% | 0 (Unchanged) | Filing History |
2024-11-15 5:05 pm Sale | 2024-11-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 5,098,211 11.000% | -103,934 (-2.00%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 5,202,145 9.990% | 1,038,934 (+24.96%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | RA Capital Management, L.P. | 5,105,213 9.000% | 692,063 (+15.68%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 9,095,589 9.990% | 898,256 (+10.96%) | Filing History |
2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,710,428 16.100% | -396,972 (-3.93%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Geron Corporation GERN | RA Capital Management, L.P. | 63,319,553 9.990% | 8,174,051 (+14.82%) | Filing History |
2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | RA Capital Management, L.P. | 761,955 4.300% | -473,644 (-38.33%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | RA Capital Management, L.P. | 766,834 1.200% | 766,834 (New Position) | Filing History |
2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | RA Capital Management, L.P. | 2,253,000 4.700% | 0 (Unchanged) | Filing History |
2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Celcuity Inc. CELC | RA Capital Management, L.P. | 1,286,960 3.400% | 0 (Unchanged) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 6,381,144 6.400% | 1,167,483 (+22.39%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA Capital Management, L.P. | 21,539,465 9.990% | 2,869,376 (+15.37%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 7,980,736 9.990% | 1,032,500 (+14.86%) | Filing History |
2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | RxSight, Inc. RXST | RA Capital Management, L.P. | 3,916,825 9.900% | 512,540 (+15.06%) | Filing History |